Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS®
Affymax, Inc. (Nasdaq: AFFY) and Takeda Pharmaceutical Company Limited (Takeda) today have decided to voluntarily recall all lots of OMONTYS® (peginesatide) Injection to the user level as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis, which can be life-threatening or fatal. The companies have been working actively with the U.S. Food and Drug Administration (FDA) which has indicated its agreement with this decision.
(C) Melissa 'Liss' Burnell & Budget101.com 1995-2016Material from www.Budget101.com may not be copied or distributed, or republished, uploaded, posted, or transmitted in any way, without the prior written consent of Budget101.com, EXCEPT: you may print recipe pages for your personal, non-commercial home use only, provided you do not delete or change any copyright, trademark, or other proprietary notices. Modification or use of the materials for any other purpose violates Budget101.com's intellectual property rights.